Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
    • Philanthropic Consulting
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

91 Biggest Movers From Friday

BY Benzinga
— 4:28 AM ET 06/13/2022

Gainers

  • RISE Education Cayman Ltd NYSE:REDU shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
  • The Singing Machine Company, Inc. NASDAQ:MICS gained 60.4% to settle at $6.72.
  • Cogent Biosciences, Inc. NASDAQ:COGT shares surged 58.7% to close at $7.87 on Friday after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
  • Alpha Tau Medical Ltd. NASDAQ:DRTS rose 40.2% to settle at $9.66. Alpha Tau Medical recently announced FDA approval of its IDE application to initiate its multi-center pivotal study for the treatment of recurrent cutaneous Squamous Cell Carcinoma using the Alpha DaRT.
  • Redbox Entertainment Inc. NASDAQ:RDBX gained 39.4% to close at $13.20 on above-average volume as the stock trended across social media platforms.
  • AeroClean Technologies, Inc. NASDAQ:AERC jumped 38.7% to close at $12.50.
  • BIMI International Medical Inc. NASDAQ:BIMI rose 30% to settle at $0.6762 after the company announced it entered a $5 million stock purchase agreement with chairman Fnu Oudom.
  • Aridis Pharmaceuticals, Inc. NASDAQ:ARDS gained 29.2% to close at $1.46.
  • Acurx Pharmaceuticals, Inc. NASDAQ:ACXP rose 23.2% to settle at $3.77.
  • Oxbridge Re Holdings Limited NASDAQ:OXBR surged 19.9% to close at $4.34.
  • Chicken Soup for the Soul Entertainment, Inc. NASDAQ:CSSE gained 19.8% to close at $8.76.
  • Nymox Pharmaceutical Corporation NASDAQ:NYMX rose 19.7% to settle at $0.5296. Nymox Pharmaceutical, last month, received a Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
  • Gold Resource Corporation NYSE:GORO jumped 19.4% to close at $2.09. Gold Resource, last month, posted Q1 EPS of $0.05.
  • Enservco Corporation NYSE:ENSV gained 17.5% to close at $3.09.
  • Quanergy Systems, Inc. NYSE:QNGY surged 17.3% to close at $0.54.
  • Borqs Technologies, Inc. NASDAQ:BRQS shares gained 16.6% to close at $0.20.
  • Arcellx, Inc. NASDAQ:ACLX jumped 16.4% to settle at $24.43.
  • Regis Corporation NYSE:RGS jumped 16.3% to close at $0.65. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations.
  • Powerbridge Technologies Co., Ltd. NASDAQ:PBTS gained 16.1% to close at $1.30 after jumping 190% on Thursday.
  • Renovare Environmental, Inc. NASDAQ:RENO rose 15.6% to settle at $0.2702.
  • Bright Green Corporation NASDAQ:BGXX gained 15.2% to close at $2.58.
  • Snow Lake Resources Ltd. NASDAQ:LITM jumped 14.8% to close at $4.58.
  • Paltalk, Inc. NASDAQ:PALT rose 14.7% to close at $2.23 after the company acquired Visicom's ManyCam assets for $2.7 million.
  • Scopus BioPharma Inc. NASDAQ:SCPS jumped 10.8% to close at $0.4490.
  • New Oriental Education & Technology Group Inc. NYSE:EDU rose 10.1% to close at $16.21 after dropping around 15% on Thursday.
  • Energy Focus, Inc. NASDAQ:EFOI gained 10% to close at $2.52. Energy Focus recently reported a $3.5 million private placement priced at-the-market under Nasdaq rules.
  • Integrated Media Technology Limited NASDAQ:IMTE gained 9.4% to close at $2.90. Integrated Media Technology announced Memorandum of Understanding to develop sourcing channel of halal products in Thailand.
  • RLX Technology Inc. NYSE:RLX shares gained 6.5% to close at $2.30.
  • Data Storage Corporation NASDAQ:DTST gained 6.4% to close at $3.34.
  • Tenax Therapeutics, Inc. NASDAQ:TENX surged 6% to close at $0.6524.


Losers

  • Revlon, Inc. NYSE:REV shares dipped 52.8% to close at $2.05. Revlon is reportedly close to filing for bankruptcy.
  • ABVC BioPharma, Inc. NASDAQ:ABVC declined 48.6% to settle at $0.90.
  • Fulcrum Therapeutics, Inc. NASDAQ:FULC shares fell 39.2% to close at $4.92 on Friday after the company announced clinical proof-of-concept data from the ongoing Phase 1b trial of FTX-6058 for the treatment of sickle cell disease.
  • G Medical Innovations Holdings Ltd NASDAQ:GMVD fell 28.5% to close at $0.3451 after declining 6% on Thursday.
  • Axcella Health Inc. NASDAQ:AXLA fell 27% to close at $2.00.
  • Bluejay Diagnostics, Inc. NASDAQ:BJDX declined 24.5% to settle at $1.23. Bluejay Diagnostics recently announced that the FDA has agreed to consider its plan to pursue a De Novo submission for the Symphony IL-6 Test.
  • DocuSign, Inc. NASDAQ:DOCU shares dropped 24.5% to close at $65.93 after the company reported weaker-than-expected earnings results for its first quarter. The company said it expects fiscal second-quarter revenue to be between $600 million and $604 million.
  • Senti Biosciences, Inc. NASDAQ:SNTI fell 24.1% to close at $4.80.
  • Cosmos Holdings Inc. NASDAQ:COSM fell 23% to close at $0.5776.
  • Immuneering Corporation NASDAQ:IMRX dipped 23% to settle at $4.95.
  • Evelo Biosciences, Inc. NASDAQ:EVLO fell 22.3% to close at $2.02.
  • Boxed, Inc. NYSE:BOXD dipped 21.9% to close at $1.96.
  • Comtech Telecommunications Corp. NASDAQ:CMTL declined 21.4% to close at $9.69 after the company reported worse-than-expected Q3 sales results.
  • 17 Education & Technology Group Inc. NASDAQ:YQ fell 21.3% to close at $2.40.
  • Dave Inc. NASDAQ:DAVE dipped 20.8% to close at $0.99.
  • Greenwich LifeSciences, Inc. NASDAQ:GLSI dropped 20.7% to close at $8.35.
  • Applied Blockchain, Inc. NASDAQ:APLD fell 20.6% to close at $2.74.
  • Caribou Biosciences, Inc. NASDAQ:CRBU dipped 20.4% to settle at $6.94 after the company reported additional data from the CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.
  • Cyclerion Therapeutics, Inc. NASDAQ:CYCN fell 20.2% to close at $0.6578 after the company announced topline clinical data for CY6463 in MELAS patients at UMDF Mitochondrial Medicine 2022 Symposium.
  • Vivos Therapeutics, Inc. NASDAQ:VVOS dipped 19.7% to close at $1.51. Vivos Therapeutics, last month, posted a Q1 loss of $0.26 per share.
  • Troika Media Group, Inc. NASDAQ:TRKA dropped 19.7% to close at $0.9401.
  • Wejo Group Limited NASDAQ:WEJO shares fell 19.5% to close at $1.57. Wejo recently announced the expansion and extension of its relationship with Microsoft Maps.
  • Omega Therapeutics, Inc. NASDAQ:OMGA dipped 19.5% to settle at $2.98.
  • Lulu's Fashion Lounge Holdings, Inc. NASDAQ:LVLU declined 19.5% to settle at $14.16. B of A Securities downgraded Lulus Fashion Lounge from Buy to Neutral and raised the price target from $14 to $21.
  • UP Fintech Holding Limited NASDAQ:TIGR fell 19% to close at $4.13 after the company reported Q1 earnings results.
  • Ampio Pharmaceuticals, Inc. NYSE:AMPE dropped 18.9% to close at $0.1835.
  • Idera Pharmaceuticals, Inc. NASDAQ:IDRA fell 18.8% to close at $0.53. Idera Pharmaceuticals, last month, reported results from an investigator-sponsored trial in melanoma patients.
  • Vivint Smart Home, Inc. NASDAQ:VVNT declined 18.8% to settle at $4.37.
  • Stitch Fix, Inc. NASDAQ:SFIX shares fell 18.5% to close at $6.34 after the company reported worse-than-expected results for its third quarter on Thursday. The company said it sees Q4 net revenue of $485 million to $495 million.
  • Blueprint Medicines Corporation NASDAQ:BPMC dipped 18.2% to close at $48.07 after Citigroup downgraded the stock from Neutral to Sell and lowered its price target from $68 to $41.
  • Aptevo Therapeutics Inc. NASDAQ:APVO declined 18.1% to close at $3.98. Aptevo Therapeutics recently announced new preliminary remission data on four additional patients enrolled in on-going APVO436 dose expansion Phase 1B Trial for the treatment of acute myeloid leukemia.
  • Zynerba Pharmaceuticals, Inc. NASDAQ:ZYNE fell 17.8% to close at $1.06.
  • Rubius Therapeutics, Inc. NASDAQ:RUBY fell 17.4% to settle at $0.9585.
  • AnPac Bio-Medical Science Co., Ltd. NASDAQ:ANPC dipped 17.3% to close at $0.2860. AnPac Bio regained compliance with requirements to remain listed on Nasdaq Capital Market.
  • WeWork Inc. NYSE:WE fell 17.2% to settle at $5.96.
  • Qutoutiao Inc. NASDAQ:QTT dropped 17.1% to settle at $1.41.
  • Apyx Medical Corporation NASDAQ:APYX fell 16.8% to close at $6.24. The U.S. Food and Drug Administration (FDA), last week, announced 510(k) clearance of Apyx Medical's Renuvion Dermal Handpiece for specific dermal resurfacing procedures.
  • Codiak BioSciences, Inc. NASDAQ:CDAK fell 16.7% to close at $2.89.
  • EBET, Inc. NASDAQ:EBET fell 15.9% to settle at $3.02. EBET entered into securities purchase agreements with institutional and accredited investors to issue 0.97 million shares and warrants to buy up to an aggregate of 0.97 million shares.
  • India Globalization Capital, Inc. NYSE:IGC dipped 15.9% to close at $0.5231. IGC recently received U.S. Patent for method and composition for treating seizure disorders, utilizing CBD.
  • 4D Molecular Therapeutics, Inc. NASDAQ:FDMT fell 15.8% to close at $6.38.
  • Werewolf Therapeutics, Inc. NASDAQ:HOWL fell 15.7% to close at $4.62.
  • Pear Therapeutics, Inc. NASDAQ:PEAR fell 15.7% to settle at $2.31.
  • Akouos, Inc. NASDAQ:AKUS declined 15.6% to close at $4.18.
  • Pineapple Energy Inc. NASDAQ:PEGY fell 15.5% to close at $2.56.
  • HyreCar Inc. NASDAQ:HYRE dipped 15.3% to settle at $1.05.
  • DBV Technologies S.A. NASDAQ:DBVT fell 15.1% to close at $2.76 after jumping around 80% on Thursday. DBV Technologies announced private placement financing of $194 million.
  • Valneva SE NASDAQ:VALN fell 15% to close at $20.00.
  • Opendoor Technologies Inc. NASDAQ:OPEN dipped 14.8% to close at $5.70.
  • Cepton, Inc. NASDAQ:CPTN dropped 14.6% to settle at $1.46.
  • Sonnet BioTherapeutics Holdings, Inc. NASDAQ:SONN tumbled 14.4% to close at $0.2527. Sonnet BioTherapeutics recently announced results from a preclinical combination study of SON-1010 with anti-PD1 checkpoint inhibition.
  • Freshworks Inc. NASDAQ:FRSH fell 13.8% to close at $12.35.
  • JanOne Inc. NASDAQ:JAN fell 13.5% to close at $3.26. JanOne, on Thursday, said its ARCA Recycling subsidiary announced it will open three new recycling centers in June and July.
  • NextPlay Technologies, Inc. NASDAQ:NXTP shares declined 12.3% to close at $0.3074 after jumping 93% on Thursday.
  • Quhuo Limited NASDAQ:QH fell 10.4% to close at $0.43.
  • Nisun International Enterprise Development Group Co., Ltd NASDAQ:NISN fell 8.2% to close at $0.78 after the company announced a buyback of up to $8 million.
  • View, Inc. NASDAQ:VIEW fell 8.2% to close at $2.35.
  • U.S. Well Services, Inc. NASDAQ:USWS shares fell 8% to close at $0.8187 after the company announced it has received a written notice from NASDAQ that co. had failed to maintain compliance with the minimum bid requirement under Nasdaq listing rule.
  • Selecta Biosciences, Inc. NASDAQ:SELB fell 7.3% to settle at $1.14.
  • Epizyme, Inc. NASDAQ:EPZM fell 6.7% to close at $0.61 after declining around 8% on Thursday.
  • GoodRx Holdings, Inc. NASDAQ:GDRX slipped 5% to close at $6.43. Goldman Sachs downgraded GoodRx Holdings from Buy to Neutral and lowered the price target from $12 to $9.

More ACXP News

  • 12 Health Care Stocks Moving In Friday's After-Market Session
    Benzinga - 5:48 PM ET 06/10/2022
  • 90 Biggest Movers From Yesterday
    Benzinga - 5:44 AM ET 05/13/2022
  • Earnings Scheduled For May 11, 2022
    Benzinga - 6:23 AM ET 05/11/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close